Personalis, Inc. (NASDAQ: PSNL) a leader in advanced genomics for cancer, today announced the pricing of its initial public offering ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE